Darzalex OverviewDaratumumab (trade name Darzalex) is an anti-cancer drug. It binds to CD38, which multiple myeloma cells overexpress. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. Daratumumab was given breakthrough therapy drug status in 2013 for multiple myeloma. I...
Read more Darzalex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daratumumab
Recent Darzalex Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 100mg/5ml, 400mg/20ml
NDC Database Records for Darzalex: (1 result)Sorted by National Drug Code
- 57894-502 Darzalex 100 mg/5ml Intravenous Injection, Solution, Concentrate by Janssen Biotech, Inc.